Search for Clinical Trial Results
Ehlers-Danlos Syndrome - 30 Studies Found
Status | Study |
Recruiting |
Study Name: Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency Condition:
Date: 2008-12-18 Interventions: Drug: Copper Histidine A physiologically acceptable form of the trace metal copper. |
Active, not recruiting |
Study Name: Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients Condition:
|
Completed |
Study Name: Biomarkers in Vascular Ehlers-Danlos Syndrome Condition: Vascular Ehlers-Danlos Syndrome Date: 2014-05-07 |
Recruiting |
Study Name: Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE) Condition: Ehlers-Danlos Syndrome, Vascular Type Date: 2015-10-23 Interventions:
|
Completed |
Study Name: Non-Invasive Quantitative Imaging of Human Local Arterial Wall Elasticity Using Supersonic Shear Imaging Condition:
Date: 2010-03-19 Interventions: Other: SSI and SphygmoCor® evaluations |
Completed |
Study Name: Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type Condition:
Date: 2005-09-13 Interventions: |
NOT_YET_RECRUITING |
Study Name: Heart Coherence Training on Vascular Ehlers-Danlos Syndrome Patients Condition: Vascular Ehlers-Danlos Syndrome Date: 2024-05-19 Interventions: The participants will all complete baseline surveys and paperwork including signed consent, psychometric surveys, demographic survey, and a brief, ope |
RECRUITING |
Study Name: Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation Condition: Hypermobile Ehlers-Danlos Syndrome Date: 2024-05-19 Interventions: Transcutaneous Auricular Neurostimulation (tAN) is a wearable, electrical stimulation device that delivers electricity to specific parts of the human |
RECRUITING |
Study Name: Identifying the Determinants of Bleeding and Hypermobility in Patients With Heavy Menstrual Bleeding Condition: Hypermobile Ehlers-Danlos Syndrome Date: 2024-05-19 |
RECRUITING |
Study Name: Impact of Oxygen Therapy on Fatigue in Patients With Hypermobile-type Ehlers-Danlos Syndrome Condition: Ehlers-Danlos Syndrome Date: 2024-05-19 Interventions: oxygen treatment (5 L/minute for 30 minutes by nasal cannula, twice/day) |